The Perceived Value of Pharmacogenetic Testing in Depression Treatment: Mixed-Methods Results From the PRIME Care Study

What is it about?

We used data from surveys and interviews to understand primary care and mental health providers' thoughts on the value and clinical utility of pharmacogenetic testing to help inform selection of medications for treating depression. Overall, our mixed methods study demonstrated that, after using the testing during a clinical trial, primary care and mental health providers have overall positive perceptions of its potential value and utility to improve depression treatment.

Featured Image